@article{b1fd5bd6c4ae4e259e20a34ceaa6ef07,
title = "Overcoming policy and financing barriers to integrated buprenorphine and HIV primary care",
abstract = "Treatment for substance abuse and human immunodeficiency virus (HIV) infection historically have come from different providers, often in separate locations, and have been reimbursed through separate funding streams. We describe policy and financing challenges faced by health care providers seeking to integrate buprenorphine, a new treatment for opioid dependence, into HIV primary care. Regulatory challenges include licensing and training restrictions imposed by the Drug Addiction Treatment Act of 2000 and confidentiality regulations for alcohol and drug treatment records. Potential responses include the development of local training programs and electronic medical records. Addressing the complexity of funding sources for integrated care will require administrative support, up-front investments, and federal and state leadership. A policy and financing research agenda should address evidence gaps in the rationales for regulatory restrictions and should include cost-effectiveness studies that quantify the {"}value for money{"} of investments in integrated care to improve health outcomes for HIV-infected patients with opioid dependence.",
author = "Schackman, {Bruce R.} and Merrill, {Joseph O.} and Dennis McCarty and Jeffrey Levi and Christine Lubinski",
note = "Funding Information: Supplement sponsorship. This article was published as part of a supplement entitled “Buprenorphine and HIV Primary Care: New Opportunities for Integrated Treatment,” sponsored by the National Institute on Drug Abuse, National Institutes of Health, Public Health Service, US Department of Health and Human Services. Funding Information: Financial support. The Forum for Collaborative HIV Research is supported by unrestricted grants from government agencies (including the National Institutes of Health, the Centers for Disease Control and Prevention, and the Health Resources and Services Administration), the pharmaceutical industry, and foundations. In addition, the forum receives project-specific funding from agencies and industry. A complete list of funding sources is available at http://www.hivforum.org/about/sponsors.htm. The Buprenorphine and HIV Primary Care Workshop was conducted in collaboration with and supported by a special grant from the Health Resources and Services Administration and was also supported, in part, by the Substance Abuse and Mental Health Services Administration.",
year = "2006",
month = dec,
day = "15",
language = "English (US)",
volume = "43",
pages = "S247--S253",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "SUPPL. 4",
}